CYTO logo

Altamira Therapeutics (CYTO) Operating Margin

Annual Operating Margin

-972.71%
+7578.05%+88.62%

December 1, 2023


Summary


Performance

CYTO Operating Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCYTOprofitabilitymetrics:

Operating Margin Formula

Operating Profit Margin =  Operating Profit
Revenue
✕ 100%

CYTO Operating Margin Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+88.6%-
3 y3 years--
5 y5 years--

CYTO Operating Margin Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+96.3%
5 y5-yearat high+96.3%
alltimeall timeat high+96.3%

Altamira Therapeutics Operating Margin History

DateAnnualQuarterly
Dec 2023
-972.71%(-88.6%)
-
DateAnnualQuarterly
Dec 2022
-8550.76%(-67.4%)
-
Dec 2021
-26.25 K%
-

FAQ

  • What is Altamira Therapeutics annual operating profit margin?
  • What is the all time high annual operating margin for Altamira Therapeutics?
  • What is Altamira Therapeutics annual operating margin year-on-year change?

What is Altamira Therapeutics annual operating profit margin?

The current annual operating margin of CYTO is -972.71%

What is the all time high annual operating margin for Altamira Therapeutics?

Altamira Therapeutics all-time high annual operating profit margin is -972.71%

What is Altamira Therapeutics annual operating margin year-on-year change?

Over the past year, CYTO annual operating profit margin has changed by +7578.05% (+88.62%)